Editorial: Alcohol‐related liver disease is the primary driver of cirrhosis‐related hospital admissions in the COVID‐19 era—What can be done?

Abstract

LINKED CONTENT This article is linked to Kim et al paper. To view this article, visit https://doi.org/10.1111/apt.17547

Quality standards on management of alcohol-related liver disease from the UK—targets and tribulations

“…This effect is postulated to be secondary to the psychosocial impact of the pandemic and increased alcohol sales during this time, which were evident in other regions including the United Kingdom (UK) ( 3 ). The lasting effects of the pandemic on ALD will be seen in the years to come, and public health measures aimed at patient advocacy and prevention are needed ( 4 ).…”